Search results
Shares of Japan's Eisai tumble after EU rejects Alzheimer's drug
Reuters via Yahoo Singapore Finance· 10 hours agoThe EU drugs regulator last week said the risk of serious brain swelling did not outweigh the drug's...
Stocks rise as US inflation data boosts rate cut hopes
AFP News via Yahoo Singapore Finance· 3 days agoMajor stock markets pushed higher Friday as traders welcomed data showing a moderation in US...
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel,...
Benzinga via Yahoo Singapore Finance· 3 days agoThe companies seek approval for the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal...
European committee says Alzheimer's treatment Leqembi shouldn't get marketing approval
Associated Press Finance via Yahoo Singapore Finance· 3 days agoShares of Biogen slid Friday after a European regulatory committee said the Alzheimer’s treatment...
Midday movers: Bristol-Myers, 3M and Deckers rise; Dexcom falls
Investing.com via Yahoo Singapore Finance· 3 days agoAon plc (NYSE:AON) rose 7%, the most in three years, after second quarter revenue beat the average analyst estimate. Results reflect organic revenue growth of 6% in its Commercial Risk Solutions ...
Is Biogen (BIIB) an Underappreciated Stock?
Insider Monkey via Yahoo Singapore Finance· 5 days agoPatient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second quarter 2024 investor letter. A...
